Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors

[Image: see text] Inhibitors of checkpoint kinase 1 (CHK1) are of current interest as potential antitumor agents, but the most advanced inhibitor series reported to date are not orally bioavailable. A novel series of potent and orally bioavailable 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbon...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Lainchbury, Michael, Matthews, Thomas P., McHardy, Tatiana, Boxall, Kathy J., Walton, Michael I., Eve, Paul D., Hayes, Angela, Valenti, Melanie R., de Haven Brandon, Alexis K., Box, Gary, Aherne, G. Wynne, Reader, John C., Raynaud, Florence I., Eccles, Suzanne A., Garrett, Michelle D., Collins, Ian
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Chemical Society 2012
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3506129/
https://ncbi.nlm.nih.gov/pubmed/23082860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm3012933
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items